Disclosed are a pyrrolotriazine derivative, a preparation method and use thereof. Specifically, disclosed are the pyrrolotriazine derivative of formula (I), a pharmaceutically acceptable salt thereof, a preparation method and use thereof as a therapeutic agent, particularly as a c-KIT inhibitor, wherein the definition of each substituent in the formula (I) is the same as defined in the description.